nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are booster doses of poliovirus vaccine necessary?
|
Salk, Jonas |
|
1990 |
8 |
5 |
p. 419-420 2 p. |
artikel |
2 |
Bordetella bronchiseptica vaccine; comprises whole B. bronchiseptica cells obtained from liquid culture and inactivated with glutaraldehyde
|
|
|
1990 |
8 |
5 |
p. 511- 1 p. |
artikel |
3 |
Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice
|
Bosseray, Nicole |
|
1990 |
8 |
5 |
p. 462-468 7 p. |
artikel |
4 |
Characteristics of inactivated hepatitis A vaccine prepared from virus propagated in heteroploid continuous monkey cell line
|
Kusov, Yu.Yu. |
|
1990 |
8 |
5 |
p. 513-514 2 p. |
artikel |
5 |
Composition containing DNA sequence encoding protein vaccine; eliciting antibody recognizing Treponema hyodysenteriae antigen
|
|
|
1990 |
8 |
5 |
p. 510- 1 p. |
artikel |
6 |
Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses
|
Nerome, Kuniaki |
|
1990 |
8 |
5 |
p. 503-509 7 p. |
artikel |
7 |
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization
|
Murphy, Brian R. |
|
1990 |
8 |
5 |
p. 497-502 6 p. |
artikel |
8 |
Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines
|
Clemens, John D. |
|
1990 |
8 |
5 |
p. 469-472 4 p. |
artikel |
9 |
Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis
|
Wild, Fabian |
|
1990 |
8 |
5 |
p. 441-442 2 p. |
artikel |
10 |
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza
|
Tamura, Shin-ichi |
|
1990 |
8 |
5 |
p. 479-485 7 p. |
artikel |
11 |
Fusion protein containing Escherichia coli and/or Shigella dysenteriae outer membrane protein-A and human influenza haemagglutinin, useful as vaccine; cell expressing it useful as live vaccine
|
|
|
1990 |
8 |
5 |
p. 512- 1 p. |
artikel |
12 |
Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies)
|
Kit, Saul |
|
1990 |
8 |
5 |
p. 420-424 5 p. |
artikel |
13 |
Genetics and Pathogenicity of Negative Strand Viruses
|
Spier, R.E. |
|
1990 |
8 |
5 |
p. 515- 1 p. |
artikel |
14 |
Haemophilus influenzae pilus vaccine is used for protection against infection and to prevent transmission to and colonization of upper respiratory tract
|
|
|
1990 |
8 |
5 |
p. 510-511 2 p. |
artikel |
15 |
Infectious-bursal-disease-virus (IBDV) vaccine for fowl; contains IBDV antigen material from mammal cell culture infected with IBDV
|
|
|
1990 |
8 |
5 |
p. 511- 1 p. |
artikel |
16 |
International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them
|
Doel, T.R. |
|
1990 |
8 |
5 |
p. 473-478 6 p. |
artikel |
17 |
Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects
|
Fescharek, Reinhard |
|
1990 |
8 |
5 |
p. 446-456 11 p. |
artikel |
18 |
Modified Bordetella pertussis toxin gene; inactive protein application in pertussis vaccine preparation
|
|
|
1990 |
8 |
5 |
p. 510- 1 p. |
artikel |
19 |
Modifying wild strain entero-invasive Shigella; genome transformation to prevent cell invasion, spreading or toxin production; enterchelin, aerobactin and/or Shiga toxin gene deletion; vaccine production
|
|
|
1990 |
8 |
5 |
p. 512- 1 p. |
artikel |
20 |
Mycobacterium expressing antigen from a pathogen; carried on a mycobacterial-bacterial hybrid vector or a lysogenizing vector; Mycobacterium smegmatis and Mycobacterium bovis used for recombinant vaccine production
|
|
|
1990 |
8 |
5 |
p. 511- 1 p. |
artikel |
21 |
New antigenic protein derived from nonA,nonB hepatitis virus is useful in vaccine and diagnosis, and related antisera and DNA fragments; DNA sequence and DNA probe
|
|
|
1990 |
8 |
5 |
p. 510- 1 p. |
artikel |
22 |
Newcastle-disease virus strain NDW CNCM I-781; fowl live vaccine
|
|
|
1990 |
8 |
5 |
p. 510- 1 p. |
artikel |
23 |
New Neisseria mutants unable to induce production of blocking antibody; Neisseria gonorrhoeae and Neisseria meningitidis lacking gene for protein PIII, useful in production of protective antigen for vaccine
|
|
|
1990 |
8 |
5 |
p. 510- 1 p. |
artikel |
24 |
New plasmid containing complete cDNA of human rhino virus-2; plasmid pHRV 2/1 vector construction; potential vaccine construction; protein engineering
|
|
|
1990 |
8 |
5 |
p. 511- 1 p. |
artikel |
25 |
Polio immunity to killed vaccine: an 18-year follow-up
|
Böttiger, Margareta |
|
1990 |
8 |
5 |
p. 443-445 3 p. |
artikel |
26 |
Poliomyelitis serosurveillance and immunization for elderly people in otherwise efficiently immunized areas
|
Arya, S.C. |
|
1990 |
8 |
5 |
p. 514- 1 p. |
artikel |
27 |
Potential use of live viral and bacterial vectors for vaccines
|
|
|
1990 |
8 |
5 |
p. 425-436 12 p. |
artikel |
28 |
Production of bluetongue virus non-structural proteins; NS1 protein gene cloning and expression in Spodoptera frugiperda cell culture; potential application in recombinant vaccine construction and diagnosis
|
|
|
1990 |
8 |
5 |
p. 512- 1 p. |
artikel |
29 |
Production of stable avirulent mutants of Legionella pneumophila for use as legionellosis vaccine and antigen targeting vector
|
|
|
1990 |
8 |
5 |
p. 512- 1 p. |
artikel |
30 |
Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins
|
Cook, R.F. |
|
1990 |
8 |
5 |
p. 491-496 6 p. |
artikel |
31 |
Protection of guinea-pigs against foot-and-mouth disease virus by immunization with a PhoE-FMDV hybrid protein
|
Agterberg, Marja |
|
1990 |
8 |
5 |
p. 438-440 3 p. |
artikel |
32 |
Pseudomonas aeruginosa outer membrane lipoprotein; recombinant vaccine construction; outer membrane protein-I gene cloning and expression in Escherichia coli; monoclonal antibody preparation and hybridoma construction
|
|
|
1990 |
8 |
5 |
p. 511-512 2 p. |
artikel |
33 |
Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses
|
Ogawa, Ryohei |
|
1990 |
8 |
5 |
p. 486-490 5 p. |
artikel |
34 |
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial
|
Storsaeter, Jann |
|
1990 |
8 |
5 |
p. 457-461 5 p. |
artikel |
35 |
Transformed salmonella bacterial strains; malaria recombinant vaccine construction; circumsporozoite antigen gene cloning and constitutive expression in attenuated Salmonella typhimurium, Salmonella dublin or Salmonella typhi
|
|
|
1990 |
8 |
5 |
p. 512- 1 p. |
artikel |
36 |
Universal vaccine for protecting pigs against Haemophilus pleuropneumoniae; toxin purification by ammonium sulphate precipitation and dialysis
|
|
|
1990 |
8 |
5 |
p. 512- 1 p. |
artikel |
37 |
Vaccination Strategies of Tropical Diseases
|
Spier, R.E. |
|
1990 |
8 |
5 |
p. 514-515 2 p. |
artikel |